Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15211037 | 0.98 | ALDH1A1 (0.42) | ALDH1A1LMNAHSD17B10CA1CA2 | |
| SCHEMBL7914744 | 0.95 | ALDH1A1 (0.40) | ALDH1A1LMNAHSD17B10CA1CA2 | |
| SCHEMBL27260870 | 0.80 | ALDH1A1 (0.41) | ALDH1A1LMNAHSD17B10CA1CA2 | |
| SCHEMBL27800302 | 0.79 | THRB (0.41) | ALDH1A1LMNAHSD17B10CA1CA2 | |
| Sulfuric Acid Diethyl Ester SCHEMBL25193310 | 0.77 | CA1 (0.43) | ALDH1A1LMNAHSD17B10CA1CA2 | |
| SCHEMBL29242383 | 0.76 | CA1 (0.39) | ALDH1A1CA1CA2 | |
| Sulfuric Acid Diethyl Ester SCHEMBL18038940 | 0.76 | CA1 (0.53) | ALDH1A1LMNACA1CA2TSHR | |
| SCHEMBL114520 | 0.76 | ALDH1A1 (0.41) | ALDH1A1LMNAHSD17B10TSHR | |
| SCHEMBL1252810 | 0.76 | THRB (0.42) | ALDH1A1LMNAHSD17B10CA1CA2 | |
| SCHEMBL25504746 | 0.74 | ALDH1A1 (0.39) | ALDH1A1LMNAHSD17B10CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119430965-A | Anti-erosion castable for waste alkali liquid incinerator and preparation method thereof | 宜兴瑞泰耐火材料有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-108484687-A | The preparation method of technetium-99 m labeled triphenylphosphine salt derivative and application | 河南中医药大学 | 2018-09-04 | — | — | CN | claimed |
| CN-103086937-A | Method for synthesizing paricalcitol | SHANGHAI PUYI CHEMICAL TECHNOLOGY CO LTD | 2013-05-08 | — | — | CN | claimed |
| CN-119430965-A | Anti-erosion castable for waste alkali liquid incinerator and preparation method thereof | 宜兴瑞泰耐火材料有限公司 | 2025-02-14 | — | — | CN | disclosed |
| US-20250049968-A1 | THERAPEUTIC AND IMAGING AGENTS FOR TARGETING MYOCARDIAL TISSUE | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2025-02-13 | — | — | US | disclosed |
| CN-118108791-A | Synthetic method of Boc-Tyr (tBu) -Aib-Glu (OtBu) -Gly-OH | 成都普康唯新生物科技有限公司 | 2024-05-31 | — | — | CN | disclosed |
| WO-2023205291-A2 | TARGETING MYOCARDIAL TISSUE FOR DELIVERY OF THERAPEUTIC AND IMAGING AGENTS | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2023-10-26 | — | — | WO | disclosed |
| CN-110431454-A | Phase difference film, multilayer phase difference film, polarizing film, image display device and polymerizable compound | ZEON CORP | 2019-11-08 | — | — | CN | disclosed |
| CN-110382514-A | Prodrugs of HCV NS5B polymerase inhibitors and methods of making and using the same | 亚历山大·瓦西里耶维奇·伊瓦切恩科 | 2019-10-25 | — | — | CN | disclosed |
| WO-2019196918-A1 | FIVE-MEMBERED HETEROCYCLO-PYRIMIDINE COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF | 罗欣药业(上海)有限公司 | 2019-10-17 | — | — | WO | disclosed |
| CN-106459627-B | Ink, cartridge, recording apparatus, printed matter, compound, composition, three-dimensional object, and material for forming three-dimensional object | 株式会社理光 | 2019-10-11 | — | — | CN | disclosed |
| CN-1034497-C | Process for the preparation of aromatic aminoalcohol derivatives useful for the treatment of diabetes and obesity | SANKYO CO (JP) | 1997-04-09 | — | — | CN | disclosed |
| CN-1033750-C | Intermediate compounds for the preparation of aromatic amino alcohol derivatives having anti-diabetic and anti-obesity properties | SANKYO CO (JP) | 1997-01-08 | — | — | CN | disclosed |
| CN-1132505-A | Amidine derivatives with nitric oxide synthetase activities | ASTERA CO (SE) | 1996-10-02 | — | — | CN | disclosed |
| CN-1106396-A | Intermediate compounds for the preparation of aromatic amino alcohol derivatives having anti-diabetic and anti-obesity properties | SANKYO CO (JP) | 1995-08-09 | — | — | CN | disclosed |
| CN-1075141-A | 1,4-dihydropyridine-3, the preparation of 5-dicarboxylic acid esters and purposes | BAYER AG (DE) | 1993-08-11 | — | — | CN | disclosed |
| CN-1073428-A | Aromatic amino alcohol derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic use | SANKYO CO (JP) | 1993-06-23 | — | — | CN | disclosed |
| CN-1015057-B | process for preparation of piperazinyl-heterocyclic compounds | PFIZER (US) | 1991-12-11 | — | — | CN | disclosed |
| CN-88101642-A | Piperazinyl-heterogeneous ring compound | — | 1988-09-14 | — | — | CN | disclosed |
| CN-85107088-A | The preparation of the heterocyclic immunostimulants that peptide replaces | — | 1986-06-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250049968-A1 | THERAPEUTIC AND IMAGING AGENTS FOR TARGETING MYOCARDIAL TISSUE | MYLK2, MYOF, MYL6 | ALDH1A1 3761/4885LMNA 812/4885HSD17B10 4271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.